Incyte Corp
(LTS:0J9P)
$
77.12
0.9112 (1.2%)
Market Cap: 14.89 Bil
Enterprise Value: 13.15 Bil
PE Ratio: 552.00
PB Ratio: 4.70
GF Score: 90/100 
Incyte Corp at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022 / 04:20PM GMT
Release Date Price:
$67.7
Andrew Scott Berens
SVB Leerink LLC, Research Division - Senior MD of Medical Supplies and Devices & Senior Research Analyst
Good morning, everyone. I'm Andy Berens, senior biotech analyst at SVB Leerink. Thank you for joining us on day 2 of our Global Healthcare Conference.
We are very happy this morning to have with us Incyte Corporation. We have Herve and Christiana and the IR team with us. Thank you for joining us. We appreciate your time and sharing the Incyte story with us.
Herve, why don't we -- yes.
Herve Hoppenot
Incyte Corporation - Chairman, President & CEO
No, no, I was going to say thank you for inviting us and we can talk the way you wish. I was planning to go quickly through a few slides and then going as quickly as we can to Q&A, if it's okay with you.
Andrew Scott Berens;Herve Hoppenot
SVB Leerink LLC, Research Division - Senior MD of Medical Supplies and Devices & Senior Research Analyst;Incyte Corporation - Chairman
Absolutely.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers